# TripAdvisor, Inc.: financial statements, quarterly

TRIP · Nasdaq · CIK 1526520 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trip.md) · [Financials](/companies/trip/financials.md) · [Filings](/companies/trip/filings.md) · [Insiders](/companies/trip/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trip/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [533](/filings/0000950170-24-122267.md) | [390 d](/filings/0001193125-26-051281.md) | [395](/filings/0000950170-25-064982.md) | [497](/filings/0000950170-25-104993.md) | [532](/filings/0001193125-25-268047.md) | [411 d](/filings/0001193125-26-051281.md) | [398](/filings/0001193125-26-210297.md) | [476](/filings/0001193125-26-336693.md) | [553](/filings/0001193125-25-268047.md) | [411 d](/filings/0001193125-26-051281.md) | [382](/filings/0001193125-26-210297.md) | [442](/filings/0001193125-26-336693.md) |
| Cost of revenue | $m | not reported | not reported | [25.0](/filings/0000950170-25-064982.md) | [36.0](/filings/0000950170-25-104993.md) | [40.0](/filings/0001193125-25-268047.md) | [28.0 d](/filings/0001193125-26-051281.md) | [26.8](/filings/0001193125-26-210297.md) | [36.5](/filings/0001193125-26-336693.md) | [41.0](/filings/0001193125-25-268047.md) | [35.0 d](/filings/0001193125-26-051281.md) | [32.8](/filings/0001193125-26-210297.md) | [33.0](/filings/0001193125-26-336693.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [14.1](/filings/0001193125-26-336693.md) | not reported | not reported | not reported | [13.1](/filings/0001193125-26-336693.md) |
| Operating income | $m | [64.0](/filings/0000950170-24-122267.md) | [32.0 d](/filings/0001193125-26-051281.md) | [(15.0)](/filings/0000950170-25-064982.md) | [36.0](/filings/0000950170-25-104993.md) | [70.0](/filings/0001193125-25-268047.md) | [0.0 d](/filings/0001193125-26-051281.md) | [(15.5)](/filings/0001193125-26-210297.md) | [57.9](/filings/0001193125-26-336693.md) | [70.0](/filings/0001193125-25-268047.md) | [(34.0) d](/filings/0001193125-26-051281.md) | [(25.2)](/filings/0001193125-26-210297.md) | [37.8](/filings/0001193125-26-336693.md) |
| Interest expense | $m | [11.0](/filings/0000950170-23-059380.md) | [11.0 d](/filings/0000950170-24-016553.md) | [11.0](/filings/0000950170-24-055051.md) | [11.0](/filings/0000950170-24-091768.md) | [13.0](/filings/0001193125-25-268047.md) | [11.0 d](/filings/0001193125-26-051281.md) | [11.7](/filings/0001193125-26-210297.md) | [17.3](/filings/0001193125-26-336693.md) | [17.0](/filings/0001193125-25-268047.md) | [16.0 d](/filings/0001193125-26-051281.md) | [15.7](/filings/0001193125-26-210297.md) | [15.0](/filings/0001193125-26-336693.md) |
| Income tax | $m | [37.0](/filings/0000950170-24-122267.md) | [0.0 d](/filings/0001193125-26-051281.md) | [43.0](/filings/0000950170-25-064982.md) | [14.0](/filings/0000950170-25-104993.md) | [27.0](/filings/0001193125-25-268047.md) | [(2.0) d](/filings/0001193125-26-051281.md) | [(9.3)](/filings/0001193125-26-210297.md) | [8.4](/filings/0001193125-26-336693.md) | [10.0](/filings/0001193125-25-268047.md) | [(7.0) d](/filings/0001193125-26-051281.md) | [0.8](/filings/0001193125-26-210297.md) | [5.3](/filings/0001193125-26-336693.md) |
| Net income | $m | [27.0](/filings/0000950170-24-122267.md) | [32.0 d](/filings/0001193125-26-051281.md) | [(59.0)](/filings/0000950170-25-064982.md) | [24.0](/filings/0000950170-25-104993.md) | [39.0](/filings/0001193125-25-268047.md) | [1.0 d](/filings/0001193125-26-051281.md) | [(11.0)](/filings/0001193125-26-210297.md) | [36.0](/filings/0001193125-26-336693.md) | [53.0](/filings/0001193125-25-268047.md) | [(38.0) d](/filings/0001193125-26-051281.md) | [(32.4)](/filings/0001193125-26-210297.md) | [22.4](/filings/0001193125-26-336693.md) |
| Diluted EPS | $ per share | [0.19](/filings/0000950170-24-122267.md) | not reported | [(0.43)](/filings/0000950170-25-064982.md) | [0.17](/filings/0000950170-25-104993.md) | [0.27](/filings/0001193125-25-268047.md) | not reported | [(0.08)](/filings/0001193125-26-210297.md) | [0.28](/filings/0001193125-26-336693.md) | [0.43](/filings/0001193125-25-268047.md) | not reported | [(0.28)](/filings/0001193125-26-210297.md) | [0.19](/filings/0001193125-26-336693.md) |
| Basic EPS | $ per share | [0.20](/filings/0000950170-24-122267.md) | not reported | [(0.43)](/filings/0000950170-25-064982.md) | [0.17](/filings/0000950170-25-104993.md) | [0.28](/filings/0001193125-25-268047.md) | not reported | [(0.08)](/filings/0001193125-26-210297.md) | [0.29](/filings/0001193125-26-336693.md) | [0.46](/filings/0001193125-25-268047.md) | not reported | [(0.28)](/filings/0001193125-26-210297.md) | [0.19](/filings/0001193125-26-336693.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,124](/filings/0000950170-23-059380.md) | [1,067](/filings/0000950170-25-023736.md) | [1,171](/filings/0000950170-24-055051.md) | [1,176](/filings/0000950170-24-091768.md) | [1,112](/filings/0000950170-24-122267.md) | [1,064](/filings/0001193125-26-051281.md) | [1,154](/filings/0000950170-25-064982.md) | [1,212](/filings/0000950170-25-104993.md) | [1,218](/filings/0001193125-25-268047.md) | [978](/filings/0001193125-26-336693.md) | [1,120](/filings/0001193125-26-210297.md) | [843](/filings/0001193125-26-336693.md) |
| Current assets | $m | [1,401](/filings/0000950170-23-059380.md) | [1,297](/filings/0000950170-25-023736.md) | [1,511](/filings/0000950170-24-055051.md) | [1,539](/filings/0000950170-24-091768.md) | [1,463](/filings/0000950170-24-122267.md) | [1,320](/filings/0001193125-26-051281.md) | [1,484](/filings/0000950170-25-064982.md) | [1,547](/filings/0000950170-25-104993.md) | [1,524](/filings/0001193125-25-268047.md) | [1,291](/filings/0001193125-26-336693.md) | [1,407](/filings/0001193125-26-210297.md) | [1,404](/filings/0001193125-26-336693.md) |
| Total assets | $m | [2,636](/filings/0000950170-23-059380.md) | [2,537](/filings/0000950170-25-023736.md) | [2,738](/filings/0000950170-24-055051.md) | [2,779](/filings/0000950170-24-091768.md) | [2,733](/filings/0000950170-24-122267.md) | [2,561](/filings/0001193125-26-051281.md) | [2,756](/filings/0000950170-25-064982.md) | [2,867](/filings/0000950170-25-104993.md) | [2,845](/filings/0001193125-25-268047.md) | [2,625](/filings/0001193125-26-336693.md) | [2,726](/filings/0001193125-26-210297.md) | [2,531](/filings/0001193125-26-336693.md) |
| Current liabilities | $m | [719](/filings/0000950170-23-059380.md) | [572](/filings/0000950170-25-023736.md) | [892](/filings/0000950170-24-055051.md) | [916](/filings/0000950170-24-091768.md) | [792](/filings/0000950170-24-122267.md) | [628](/filings/0001193125-26-051281.md) | [783](/filings/0000950170-25-064982.md) | [1,249](/filings/0000950170-25-104993.md) | [1,150](/filings/0001193125-25-268047.md) | [998](/filings/0001193125-26-336693.md) | [1,126](/filings/0001193125-26-210297.md) | [899](/filings/0001193125-26-336693.md) |
| Total liabilities | $m | [1,813](/filings/0000950170-23-059380.md) | [1,666](/filings/0000950170-25-023736.md) | [1,913](/filings/0000950170-24-055051.md) | [1,922](/filings/0000950170-24-091768.md) | [1,789](/filings/0000950170-24-122267.md) | [1,618](/filings/0001193125-26-051281.md) | [2,113](/filings/0000950170-25-064982.md) | [2,240](/filings/0000950170-25-104993.md) | [2,138](/filings/0001193125-25-268047.md) | [1,981](/filings/0001193125-26-336693.md) | [2,102](/filings/0001193125-26-210297.md) | [1,869](/filings/0001193125-26-336693.md) |
| Long-term debt | $m | [839](/filings/0000950170-23-059380.md) | [839](/filings/0000950170-25-023736.md) | [840](/filings/0000950170-24-055051.md) | [841](/filings/0000950170-24-091768.md) | [832](/filings/0000950170-24-122267.md) | [831](/filings/0001193125-26-051281.md) | [1,167](/filings/0000950170-25-064982.md) | [822](/filings/0000950170-25-104993.md) | [821](/filings/0001193125-25-268047.md) | [819](/filings/0001193125-26-336693.md) | [818](/filings/0001193125-26-210297.md) | [816](/filings/0001193125-26-336693.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0000950170-25-023736.md) | not reported | not reported | [5.0](/filings/0000950170-24-122267.md) | [5.0](/filings/0001193125-26-051281.md) | [9.0](/filings/0000950170-25-064982.md) | [353](/filings/0000950170-25-104993.md) | [353](/filings/0001193125-25-268047.md) | [353](/filings/0001193125-26-336693.md) | [354](/filings/0001193125-26-210297.md) | [8.5](/filings/0001193125-26-336693.md) |
| Shareholders' equity | $m | [823](/filings/0000950170-24-122267.md) | [871](/filings/0001193125-26-051281.md) | [825](/filings/0000950170-25-104993.md) | [857](/filings/0001193125-25-268047.md) | [944](/filings/0001193125-25-268047.md) | [943](/filings/0001193125-26-336693.md) | [643](/filings/0001193125-26-336693.md) | [627](/filings/0001193125-26-336693.md) | [707](/filings/0001193125-25-268047.md) | [645](/filings/0001193125-26-336693.md) | [624](/filings/0001193125-26-336693.md) | [663](/filings/0001193125-26-336693.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.0 d](/filings/0000950170-24-122267.md) | [(19.0) d](/filings/0001193125-26-051281.md) | [139](/filings/0000950170-25-064982.md) | [51.0 d](/filings/0000950170-25-104993.md) | [(43.0) d](/filings/0001193125-25-268047.md) | [(3.0) d](/filings/0001193125-26-051281.md) | [102](/filings/0001193125-26-210297.md) | [202 d](/filings/0001193125-26-336693.md) | [44.5 d](/filings/0001193125-25-268047.md) | [(103) d](/filings/0001193125-26-051281.md) | [118](/filings/0001193125-26-210297.md) | [144 d](/filings/0001193125-26-336693.md) |
| Capital expenditure | $m | [16.0 d](/filings/0000950170-24-122267.md) | [16.0 d](/filings/0001193125-26-051281.md) | [16.0](/filings/0000950170-25-064982.md) | [15.0 d](/filings/0000950170-25-104993.md) | [20.0 d](/filings/0001193125-25-268047.md) | [23.0 d](/filings/0001193125-26-051281.md) | [19.0](/filings/0001193125-26-210297.md) | [15.3 d](/filings/0001193125-26-336693.md) | [28.7 d](/filings/0001193125-25-268047.md) | [19.0 d](/filings/0001193125-26-051281.md) | [16.5](/filings/0001193125-26-210297.md) | [6.0 d](/filings/0001193125-26-336693.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122267.md) | [25.0 d](/filings/0001193125-26-051281.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-268047.md) | [0.0 d](/filings/0001193125-26-051281.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-268047.md) | [50.0 d](/filings/0001193125-26-051281.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [146](/filings/0000950170-23-059380.md) | [141](/filings/0000950170-24-055051.md) | [145](/filings/0000950170-24-091768.md) | [143](/filings/0000950170-24-122267.md) | [138](/filings/0000950170-25-064982.md) | [145](/filings/0000950170-25-104993.md) | [144](/filings/0001193125-25-268047.md) | [141](/filings/0001193125-26-210297.md) | [130](/filings/0001193125-26-336693.md) | [124](/filings/0001193125-25-268047.md) | [115](/filings/0001193125-26-210297.md) | [118](/filings/0001193125-26-336693.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 117,199,342 at 2026-06-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-336693.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.